Total Payments
$20,278
2024 Payments
$3,672
Companies
71
Transactions
1,304
Medicare Patients
4,002
Medicare Billing
$555,783
Payment Breakdown by Category
Food & Beverage$19,461 (96.0%)
Education$675.32 (3.3%)
Other$142.04 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,461 | 1,275 | 96.0% |
| Education | $675.32 | 18 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $142.04 | 11 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,821 | 89 | $0 (2024) |
| Biogen, Inc. | $1,551 | 103 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,391 | 104 | $0 (2024) |
| Lundbeck LLC | $1,071 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,032 | 62 | $0 (2024) |
| ABBVIE INC. | $993.02 | 74 | $0 (2024) |
| GENZYME CORPORATION | $860.49 | 44 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $855.93 | 72 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $841.83 | 87 | $0 (2022) |
| EMD Serono, Inc. | $782.61 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,672 | 185 | UCB, Inc. ($627.53) |
| 2023 | $3,475 | 220 | Sumitomo Pharma America, Inc. ($415.89) |
| 2022 | $3,030 | 183 | Biogen, Inc. ($347.06) |
| 2021 | $1,880 | 120 | GENZYME CORPORATION ($213.29) |
| 2020 | $588.77 | 36 | Biogen, Inc. ($82.34) |
| 2019 | $2,701 | 184 | Teva Pharmaceuticals USA, Inc. ($334.51) |
| 2018 | $2,782 | 197 | Biogen, Inc. ($330.49) |
| 2017 | $2,149 | 179 | Lundbeck LLC ($259.10) |
All Payment Transactions
1,304 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.90 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: NEUROLOGY | ||||||
| 12/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.82 | General |
| 12/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neurology | ||||||
| 12/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.90 | General |
| 12/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.05 | General |
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Neurology | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: PAIN | ||||||
| 12/02/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| 11/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Central Nervous System | ||||||
| 11/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: Neurology | ||||||
| 11/07/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 979 | 1,565 | $357,858 | $138,766 |
| 2022 | 9 | 970 | 1,466 | $309,203 | $126,961 |
| 2021 | 11 | 1,000 | 1,590 | $327,011 | $141,824 |
| 2020 | 10 | 1,053 | 1,858 | $347,648 | $148,232 |
Total Patients
4,002
Total Services
6,479
Medicare Billing
$555,783
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 334 | 763 | $154,126 | $61,163 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 196 | 324 | $56,700 | $18,556 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 98 | 123 | $27,675 | $14,510 | 52.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 58 | 59 | $20,650 | $13,358 | 64.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 81 | 81 | $30,375 | $11,778 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $17,226 | $6,633 | 38.5% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 30 | 30 | $10,500 | $5,983 | 57.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 26 | 26 | $14,690 | $2,211 | 15.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 22 | 24 | $15,000 | $2,112 | 14.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,366 | $1,392 | 41.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 47 | 48 | $3,120 | $757.23 | 24.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 11 | 11 | $4,430 | $313.48 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 320 | 616 | $124,323 | $48,180 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 205 | 299 | $67,275 | $33,211 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 253 | $44,275 | $14,527 | 32.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 91 | 91 | $34,125 | $13,246 | 38.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 57 | 57 | $20,015 | $13,199 | 65.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,940 | $2,315 | 39.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 15 | 16 | $9,040 | $1,295 | 14.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 49 | 50 | $3,250 | $799.65 | 24.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 60 | 64 | $960.00 | $188.10 | 19.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 456 | 1,003 | $180,516 | $82,836 | 45.9% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 86 | 87 | $30,450 | $20,499 | 67.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 104 | 113 | $25,450 | $14,849 | 58.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 73 | 73 | $19,297 | $7,577 | 39.3% |
About Dr. Daniel Donovan, MD
Dr. Daniel Donovan, MD is a Neurology healthcare provider based in Cookeville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629068994.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Donovan, MD has received a total of $20,278 in payments from pharmaceutical and medical device companies, with $3,672 received in 2024. These payments were reported across 1,304 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($19,461).
As a Medicare-enrolled provider, Donovan has provided services to 4,002 Medicare beneficiaries, totaling 6,479 services with total Medicare billing of $555,783. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cookeville, TN
- Active Since 10/26/2005
- Last Updated 11/07/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1629068994
Products in Payments
- APTIOM (Drug) $1,395
- Briviact (Drug) $1,019
- REXULTI (Drug) $786.57
- AUBAGIO (Drug) $750.07
- KESIMPTA (Drug) $581.30
- AUSTEDO (Drug) $548.02
- NURTEC ODT (Drug) $519.07
- TROKENDI XR (Drug) $516.89
- NUEDEXTA (Drug) $507.88
- UBRELVY (Drug) $483.66
- Fycompa (Drug) $441.85
- TECFIDERA (Drug) $415.13
- TYSABRI (Biological) $408.23
- BOTOX (Biological) $355.24
- VYEPTI (Biological) $344.96
- VRAYLAR (Drug) $344.26
- VUMERITY (Drug) $301.65
- Aimovig (Biological) $298.63
- MAVENCLAD (Drug) $293.24
- ZEPOSIA (Drug) $283.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cookeville
Dr. Ronak Jani, M.d, M.D
Neurology — Payments: $75,009
Neurology $75,009
Supriya Kohli, M.d, M.D
Neurology — Payments: $23,185
Neurology $23,185
Dr. Lanny Turkewitz, M,D, M,D
Neurology — Payments: $3,789
Neurology $3,789
Randy Gaw, Md, MD
Neurology — Payments: $554.90
Neurology $554.90
Dalia Miller, Md, MD
Neurology — Payments: $68.22
Neurology $68.22
Dr. Mark Tedford, M.d, M.D
Neurology — Payments: $17.56
Neurology $17.56